[Resistance of Haemophilus influenzae and Haemophilus parainfluenzae to beta-lactam antibiotics. Characterization of the beta-lactamases]. 1992

M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
Instituto Municipal de Investigación Médica, Universidad Autónoma, Barcelona.

We have studied the susceptibility to ampicillin and the characteristics of the beta-lactamase activity of the 169 Haemophilus spp. strains (128 H. influenzae, 40 H. parainfluenzae and one H. paraphrophilus) isolated during 12 months, years 1988-1989, in the Hospital del Mar clinical microbiology laboratory. Our objective was to know in the strains of our center the frequency of those resistant or slightly susceptible to ampicillin, the role of beta-lactamases in the loss of susceptibility and the type of enzymes involved. Susceptibility was studied by diffusion for all the antibiotics tested and also confirmed by dilution for ampicillin and other beta-lactam antibiotics. Beta-lactamase production was identified by nitrocefin hydrolysis. The isoelectric point of the beta-lactamase and the identification of their types were determined by analytic isoelectric focusing. The presence of the codifying gene of the TEM-1 enzyme was studied by hybridization with a TEM-1 probe. Of the H. influenzae strains 35 were ampicillin resistant, one moderately susceptible and of the H. parainfluenzae strains six were resistant and two moderately susceptible; all were susceptible to the combination of amoxicillin/clavulanic acid. The ampicillin-resistant strains were beta-lactamase producers. In 40 strains, by isoelectric focusing, the type TEM-1 was identified and the hybridization was positive; in one H. parainfluenzae strain a beta-lactamase of pl 5.8 was observed and the hybridization with TEM-1 probe was negative. The three strains moderately susceptible to ampicillin did not produce beta-lactamase.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006190 Haemophilus A genus of PASTEURELLACEAE that consists of several species occurring in animals and humans. Its organisms are described as gram-negative, facultatively anaerobic, coccobacillus or rod-shaped, and nonmotile. Hemophilus
D006192 Haemophilus Infections Infections with bacteria of the genus HAEMOPHILUS. Hemophilus Infections,Haemophilus influenzae Infection,Haemophilus influenzae Type b Infection,Hib Infection,Infections, Haemophilus,Infections, Hemophilus,Haemophilus Infection,Haemophilus influenzae Infections,Hemophilus Infection,Hib Infections,Infection, Haemophilus,Infection, Haemophilus influenzae,Infection, Hemophilus,Infection, Hib
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin
D000668 Ampicillin Resistance Nonsusceptibility of a microbe to the action of ampicillin, a penicillin derivative that interferes with cell wall synthesis. Ampicillin Resistances,Resistance, Ampicillin,Resistances, Ampicillin
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial

Related Publications

M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
August 1985, Antimicrobial agents and chemotherapy,
M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
October 1974, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
February 1998, Medicina clinica,
M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
August 1981, Antimicrobial agents and chemotherapy,
M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
May 2013, The Journal of antimicrobial chemotherapy,
M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
October 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
June 2016, Microbial drug resistance (Larchmont, N.Y.),
M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
January 1992, Journal of hygiene, epidemiology, microbiology, and immunology,
M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
February 1978, Antimicrobial agents and chemotherapy,
M Tirado, and M T Baró, and M Hermida, and M Morta, and C Alia, and C Roy
February 2012, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!